AR037211A1 - Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1 - Google Patents
Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1Info
- Publication number
- AR037211A1 AR037211A1 ARP020104215A ARP020104215A AR037211A1 AR 037211 A1 AR037211 A1 AR 037211A1 AR P020104215 A ARP020104215 A AR P020104215A AR P020104215 A ARP020104215 A AR P020104215A AR 037211 A1 AR037211 A1 AR 037211A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- heteroarilo
- orl
- derivatives
- independently selected
- Prior art date
Links
- 102100028646 Nociceptin receptor Human genes 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 108010020615 nociceptin receptor Proteins 0.000 title 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- -1 1-piperazinyl Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Reivindicación 1: Un compuesto representado por la fórmula (1) o las sales farmacéuticamente aceptables del mismo, en el cual R es R4-heteroarilo o fórmula (2); R1 es H ó alquilo C1-6; R2 y R3 son independientemente seleccionados entre el grupo que consiste en -CH3, -OCH3, flúor, cloro, bromo y yodo; R4 representa 1 a 4 sustituyentes independientemente seleccionados entre el grupo que consiste en H, halo, alquilo C1-6, -CN, -CF3, -OCF3, -(CH2)n-OR5-; -(CH2)n-NR5R6, -(CH2)n-NHSO2R5, -(CH2)n-NH(CH2)2NR5R6, -(CH2)n-NHC(O)NR5R7, -(CH2)n-NH(CH2)2OR5 t 1-piperazinilo; n es 0, 1 ó 3; R5 y R6 son independientemente seleccionados entre el grupo que consiste en H y alquilo C1-3 y R7 es H, alquilo C1-3 o aminoalquilo C1-3; ó una sal o solvato farmacéuticamente aceptable de los mismos, composiciones farmacéuticas elaborados con los mismos y el uso de dichos compuestos en el tratamiento del dolor, ansiedad, la tos, el asma, la depresión y el alcoholismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33328401P | 2001-11-07 | 2001-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR037211A1 true AR037211A1 (es) | 2004-10-27 |
Family
ID=23302135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020104215A AR037211A1 (es) | 2001-11-07 | 2002-11-05 | Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6727254B2 (es) |
| EP (1) | EP1442036B1 (es) |
| JP (2) | JP4246066B2 (es) |
| KR (1) | KR100596261B1 (es) |
| CN (1) | CN1252068C (es) |
| AR (1) | AR037211A1 (es) |
| AT (1) | ATE315566T1 (es) |
| BR (1) | BR0213907A (es) |
| CA (1) | CA2465871C (es) |
| CY (1) | CY1105208T1 (es) |
| DE (1) | DE60208724T2 (es) |
| DK (1) | DK1442036T3 (es) |
| EC (1) | ECSP045096A (es) |
| ES (1) | ES2256590T3 (es) |
| HU (1) | HUP0402329A2 (es) |
| IL (2) | IL161120A0 (es) |
| MX (1) | MXPA04004276A (es) |
| MY (1) | MY126268A (es) |
| NO (1) | NO329026B1 (es) |
| NZ (1) | NZ532088A (es) |
| PE (1) | PE20030719A1 (es) |
| PL (1) | PL370269A1 (es) |
| RU (1) | RU2327698C2 (es) |
| TW (1) | TWI317360B (es) |
| WO (1) | WO2003039469A2 (es) |
| ZA (1) | ZA200403404B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| US20040067950A1 (en) * | 1998-07-27 | 2004-04-08 | Schering-Plough Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| JP4903385B2 (ja) * | 2002-12-06 | 2012-03-28 | パーデュー・リサーチ・ファウンデーション | 損傷した哺乳類神経組織を治療するためのピリジン類 |
| US8729107B2 (en) * | 2002-12-06 | 2014-05-20 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| WO2005089761A1 (en) * | 2004-03-17 | 2005-09-29 | Pfizer Limited | Combination for treating inflammatory diseases |
| CN100577661C (zh) * | 2004-09-15 | 2010-01-06 | 先灵-普劳有限公司 | 取代的8-氮杂双环[3.2.1]辛-3-醇的制备方法 |
| DE102005016460A1 (de) | 2005-04-11 | 2006-10-19 | Grünenthal GmbH | Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit |
| PE20071159A1 (es) | 2005-10-31 | 2007-11-30 | Schering Corp | Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| MY153948A (en) * | 2008-07-21 | 2015-04-15 | Purdue Pharma Lp | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| GB201004311D0 (en) | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
| GB201115853D0 (en) | 2011-09-14 | 2011-10-26 | Proximagen Ltd | New enzyme inhibitor compounds |
| US9724340B2 (en) * | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
| WO2025085818A1 (en) * | 2023-10-19 | 2025-04-24 | Purdue Pharma L.P. | Sunobinop for use in method of treating alcohol use disorder |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| TW590268U (en) * | 2000-08-08 | 2004-06-01 | Wistron Corp | Heat dissipating device |
-
2002
- 2002-11-05 TW TW091132573A patent/TWI317360B/zh not_active IP Right Cessation
- 2002-11-05 PE PE2002001078A patent/PE20030719A1/es not_active Application Discontinuation
- 2002-11-05 MY MYPI20024131A patent/MY126268A/en unknown
- 2002-11-05 AR ARP020104215A patent/AR037211A1/es unknown
- 2002-11-06 RU RU2004117542/04A patent/RU2327698C2/ru not_active IP Right Cessation
- 2002-11-06 NZ NZ532088A patent/NZ532088A/en not_active IP Right Cessation
- 2002-11-06 ES ES02802860T patent/ES2256590T3/es not_active Expired - Lifetime
- 2002-11-06 DK DK02802860T patent/DK1442036T3/da active
- 2002-11-06 DE DE60208724T patent/DE60208724T2/de not_active Expired - Lifetime
- 2002-11-06 MX MXPA04004276A patent/MXPA04004276A/es active IP Right Grant
- 2002-11-06 EP EP02802860A patent/EP1442036B1/en not_active Expired - Lifetime
- 2002-11-06 KR KR1020047006246A patent/KR100596261B1/ko not_active Expired - Fee Related
- 2002-11-06 US US10/288,976 patent/US6727254B2/en not_active Expired - Fee Related
- 2002-11-06 JP JP2003541761A patent/JP4246066B2/ja not_active Expired - Fee Related
- 2002-11-06 HU HU0402329A patent/HUP0402329A2/hu unknown
- 2002-11-06 IL IL16112002A patent/IL161120A0/xx unknown
- 2002-11-06 WO PCT/US2002/035539 patent/WO2003039469A2/en not_active Ceased
- 2002-11-06 BR BR0213907-3A patent/BR0213907A/pt not_active Application Discontinuation
- 2002-11-06 PL PL02370269A patent/PL370269A1/xx unknown
- 2002-11-06 AT AT02802860T patent/ATE315566T1/de active
- 2002-11-06 CN CNB028220226A patent/CN1252068C/zh not_active Expired - Fee Related
- 2002-11-06 CA CA002465871A patent/CA2465871C/en not_active Expired - Fee Related
-
2004
- 2004-03-28 IL IL161120A patent/IL161120A/en not_active IP Right Cessation
- 2004-05-05 ZA ZA200403404A patent/ZA200403404B/en unknown
- 2004-05-06 EC EC2004005096A patent/ECSP045096A/es unknown
- 2004-06-04 NO NO20042294A patent/NO329026B1/no not_active IP Right Cessation
-
2006
- 2006-04-07 CY CY20061100498T patent/CY1105208T1/el unknown
-
2008
- 2008-08-14 JP JP2008209104A patent/JP2009035556A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR037211A1 (es) | Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1 | |
| HRP20110957T1 (hr) | Derivati kinolina kao inhibitori fosfodiesteraza | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| PE20020721A1 (es) | Derivados de quinuclidina como agentes antimuscarinicos m3 | |
| AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
| AR045180A1 (es) | Derivados 3-amino cromado y 2-amino tetralina y composiciones que contienen a dichos compuestos | |
| AR046711A1 (es) | 5-7-diaminopirazolo[4,3d]pirimidinas como inhibidores de la pde-5,composiciones farmaceuticas que las contienen y usos en el tratamiento de hipertensiones | |
| PE20030762A1 (es) | Compuestos heterociclicos como antagonistas nk1 | |
| ME00555A (en) | Tryasolyl tropane derivatives as ccr5 modulators | |
| CO5611139A2 (es) | Pirimidinas aril sustituidas y el uso de las mismas | |
| PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
| AR037534A1 (es) | Derivado de adamantano, su uso en la fabricacion de un medicamento para usar en terapia, composicion farmaceutica, proceso para la preparacion de dicho compuesto y dicha composicion y compuestos intermediarios | |
| PE20050489A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos | |
| AR034009A1 (es) | Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos | |
| AR044874A1 (es) | Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica | |
| EA200300718A1 (ru) | Производные 3-индолина, которые могут применяться при лечении психиатрических и неврологических расстройств | |
| CO2020001326A2 (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| AR056613A1 (es) | Compuestos derivados de lapachona, su preparacion y metodos de uso de los mismos para el tratamiento o prevencion de trastornos proliferativos celulares y composiciones farmaceuticas que los contienen | |
| NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| AR041246A1 (es) | Derivados de piridina; un procedimiento de preparacion de los mismos y composicion farmaceutica que los contiene | |
| PE20242216A1 (es) | Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2 | |
| HRP20070529T3 (hr) | Derivati imidazola kao antagonisti receptora glutamata | |
| AR049464A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos. composiciones farmaceuticas | |
| AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |